Download PDF
CC BY-NC-ND 4.0 · Nuklearmedizin 2023; 62(02): 73-74
DOI: 10.1055/a-1996-0157
Case Report

F18-FDG PET/CT in a patient with Antisynthetase Syndrome

F18-FDG-PET/CT bei einem Patienten mit Antisynthetase-Syndrom
Tina Nazerani-Zemann
1   Radiology, Division of Nuclear Medicine, Medizinische Universität Graz, Graz, Austria (Ringgold ID: RIN31475)
,
Susanne Stanzel
1   Radiology, Division of Nuclear Medicine, Medizinische Universität Graz, Graz, Austria (Ringgold ID: RIN31475)
,
Christian Gstettner
1   Radiology, Division of Nuclear Medicine, Medizinische Universität Graz, Graz, Austria (Ringgold ID: RIN31475)
,
Reingard Maria Aigner
1   Radiology, Division of Nuclear Medicine, Medizinische Universität Graz, Graz, Austria (Ringgold ID: RIN31475)
,
Birgit Pernthaler
1   Radiology, Division of Nuclear Medicine, Medizinische Universität Graz, Graz, Austria (Ringgold ID: RIN31475)
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

More prevalent in women than men, Antisynthetase Syndrome is a rare and poorly defined autoimmune disease associated with interstitial lung disease, polymyositis, and dermatomyositis. In addition to various diagnostic tools, imaging modalities are needed in certain situations. A 42-year-old woman with Anti-Jo-1-positive Antisynthetase Syndrome presented with thoracic muscular pain. She underwent whole-body Fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) to evaluate the total extent of the muscles affected. Depicting symptomatic symmetric myositis of the intercostal muscles, F18-FDG PET/CT additionally revealed unusually extensive fasciitis of the lower extremities.

Keywords

F18-FDG-PET/CT, Antisynthetase Syndrome, Fasciitis


Publication History

Received: 07 November 2022

Accepted: 08 November 2022

Article published online:
04 January 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Fukamatsu H, Hirai Y, Miyake T. et al. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies. J Dermatol 2019; 46: 886-897
    CrossrefPubMedSearch in Google Scholar
  • 2 Matuszak J, Blondet C, Hubelé F. et al. Muscle fluorodeoxyglucose uptake assessed by positron emission tomography–computed tomography as a biomarker of inflammatory myopathies disease activity. Rheumatology 2019; 58: 1459-1464
    CrossrefPubMedSearch in Google Scholar
  • 3 Bains S, Reimert M, Win AZ. et al. A Patient with Psoriatic Arthritis Imaged with FDG-PET/CT Demonstrated an Unusual Imaging Pattern with Muscle and Fascia Involvement: A Case Report. Nucl Med Mol Imaging 2012; 46: 138-143
    CrossrefPubMedSearch in Google Scholar
  • 4 Jain TK, Basher RK, Bhattacharya A. et al. 18F-FDG PET/CT in diagnosis and response evaluation in an unusual case of antisynthetase syndrome presenting as pyrexia of unknown origin. Rev Esp Med Nucl Imagen Mol 2016; 35: 197-199
    CrossrefPubMedSearch in Google Scholar
  • 5 Ebbo M, Chagnaud C, Figarella-Branger D. et al. Antisynthethase syndrome presenting as peripheral limb fasciitis. Joint Bone Spine 2013; 80: 528-530
    CrossrefPubMedSearch in Google Scholar
  • 6 Clarencon F, Larousserie F, Babinet A. et al. FDG PET/CT findings in a case of myositis ossificans circumscripta of the forearm. Clin Nucl Med 2011; 36: 40-42
    CrossrefPubMedSearch in Google Scholar
  • 7 Hotta M, Minamimoto R, Kaneko H. et al. Fluorodeoxyglucose PET/CT of Arthritis in Rheumatic Diseases: A Pictorial Review. RadioGraphics 2020; 40: 223-240
    CrossrefPubMedSearch in Google Scholar
  • 8 Kubota K, Yamashita H, Mimori A. Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis. Seminars in Nuclear Medicine 2017; 47: 408-424
    CrossrefPubMedSearch in Google Scholar